Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.

Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.

Resource Type

CF Research News

Authors

Bernstein AT, Leigh MW, Goralski JL, Esther CR Jr, McKinzie CJ.

References

J Cyst Fibros. 2018 Nov;17(6):e48-e50. doi: 10.1016/j.jcf.2018.08.003.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Child [3]
MRSA [4]
Pediatric [5]
Telavancin [6]
Vancomycin [7]

Date

Saturday, November 17, 2018

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/use-telavancin-adolescent-patients-cystic-fibrosis-and-prior

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-18-00135R1_FINAL_McKinzie_081118.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=USE%20OF%20TELAVANCIN%20IN%20ADOLESCENT%20PATIENTS%20WITH%20CYSTIC%20FIBROSIS%20AND%20PRIOR%20INTOLERANCE%20TO%20VANCOMYCIN%3A%20A%20CASE%20SERIES [3] https://www.ecfs.eu/research-article-keywords/child [4] https://www.ecfs.eu/research-article-keywords/mrsa [5] https://www.ecfs.eu/research-article-keywords/pediatric [6] https://www.ecfs.eu/research-article-keywords/telavancin [7] https://www.ecfs.eu/research-article-keywords/vancomycin [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines